These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32730542)

  • 1. Immunotolerance induction effectivity in hemophilia A children and neutralizing alloantibodies.
    Soto A V; Cortez S D; González S M
    Rev Chil Pediatr; 2020 Apr; 91(2):232-238. PubMed ID: 32730542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ITI Treatment is not First-Choice Treatment in Children with Hemophilia A and Low-Responding Inhibitors: Evidence from a PedNet Study.
    van den Berg HM; Mancuso ME; Königs C; D'Oiron R; Platokouki H; Mikkelsen TS; Motwani J; Nolan B; Santagostino E;
    Thromb Haemost; 2020 Aug; 120(8):1166-1172. PubMed ID: 32572865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience.
    Kurth M; Puetz J; Kouides P; Sanders J; Sexauer C; Bernstein J; Gruppo R; Manco-Johnson M; Neufeld EJ; Rodriguez N; Wicklund B; Quon D; Aledort L
    J Thromb Haemost; 2011 Nov; 9(11):2229-34. PubMed ID: 21883884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
    Kreuz W; Escuriola Ettingshausen C; Vdovin V; Zozulya N; Plyushch O; Svirin P; Andreeva T; Bubanská E; Campos M; Benedik-Dolničar M; Jiménez-Yuste V; Kitanovski L; Klukowska A; Momot A; Osmulskaya N; Prieto M; Šalek SZ; Velasco F; Pavlova A; Oldenburg J; Knaub S; Jansen M; Belyanskaya L; Walter O; ;
    Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early eradication of factor VIII inhibitor in patients with congenital hemophilia A by immune tolerance induction with a high dose of immunoglobulin.
    Mizoguchi Y; Furue A; Kagawa R; Chijimatsu I; Tomioka K; Shimomura M; Imanaka Y; Nishimura S; Saito S; Miki M; Ono A; Konishi N; Kawaguchi H; Kobayashi M
    Int J Hematol; 2016 Apr; 103(4):473-7. PubMed ID: 26830966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor recurrence after immune tolerance induction: a multicenter retrospective cohort study.
    Antun A; Monahan PE; Manco-Johnson MJ; Callaghan MU; Kanin M; Knoll C; Carpenter SL; Davis JA; Guerrera MF; Kruse-Jarres R; Ragni MV; Witmer C; McCracken CE; Kempton CL
    J Thromb Haemost; 2015 Nov; 13(11):1980-8. PubMed ID: 26382916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-A2 and anti-A1 domain antibodies are potential predictors of immune tolerance induction outcome in children with hemophilia A.
    Lapalud P; Rothschild C; Mathieu-Dupas E; Balicchi J; Gruel Y; Laune D; Molina F; Schved JF; Granier C; Lavigne-Lissalde G
    J Thromb Haemost; 2015 Apr; 13(4):540-7. PubMed ID: 25603934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.
    Nakar C; Manco-Johnson MJ; Lail A; Donfield S; Maahs J; Chong Y; Blades T; Shapiro A
    Haemophilia; 2015 May; 21(3):365-373. PubMed ID: 25581638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
    Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
    Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens.
    Lin PC; Liao YM; Tsai SP; Chang TT
    Pediatr Blood Cancer; 2011 Dec; 57(6):1029-33. PubMed ID: 21793191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors.
    Unuvar A; Warrier I; Lusher JM
    Haemophilia; 2000 May; 6(3):150-7. PubMed ID: 10792472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful immune tolerance induction with a plasma-derived FVIII concentrate and intravenous immunoglobulins in a pediatric patient with congenital severe hemophilia A and poor prognostic factors.
    de Cos C; Rodríguez-Martorell J
    Blood Coagul Fibrinolysis; 2014 Jan; 25(1):77-80. PubMed ID: 24231694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
    Sakurai Y; Shima M; Tanaka I; Fukuda K; Yoshida K; Yoshioka A
    Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study.
    Rothschild C; D'Oiron R; Borel-Derlon A; Gruel Y; Navarro R; Negrier C
    Haemophilia; 2013 Mar; 19(2):281-6. PubMed ID: 23038998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.
    Oldenburg J; Jiménez-Yuste V; Peiró-Jordán R; Aledort LM; Santagostino E
    Haemophilia; 2014 Jan; 20(1):83-91. PubMed ID: 24354480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study.
    Rivard GE; Rothschild C; Toll T; Achilles K
    Haemophilia; 2013 May; 19(3):449-55. PubMed ID: 23510123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
    Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of inhibitor eradication in clinically complicated hemophilia A patients.
    Oldenburg J; Young G; Santagostino E; Escuriola Ettingshausen C
    Expert Rev Hematol; 2018 Nov; 11(11):857-862. PubMed ID: 30286680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).
    Rocino A; Cortesi PA; Scalone L; Mantovani LG; Crea R; Gringeri A; ;
    Haemophilia; 2016 Jan; 22(1):96-102. PubMed ID: 26278414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.